NPI: 1003281452 · HENDERSON, NV 89011 · General Acute Care Hospital · NPI assigned 12/10/2015
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (CFO, SENIOR VP) |
| NPI Enumeration Date | 12/10/2015 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 105,282 | $1.70M |
| 2019 | 311,149 | $6.37M |
| 2020 | 259,140 | $5.33M |
| 2021 | 282,234 | $6.47M |
| 2022 | 308,650 | $7.50M |
| 2023 | 323,203 | $7.94M |
| 2024 | 268,672 | $7.07M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 71,648 | 59,658 | $8.16M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 46,815 | 41,518 | $4.10M |
| G0378 | Hospital observation service, per hour | 27,843 | 19,923 | $3.47M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 13,703 | 11,802 | $3.11M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 45,965 | 38,516 | $2.41M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 8,318 | 7,253 | $1.31M |
| 70450 | Computed tomography, head or brain; without contrast material | 14,510 | 12,565 | $1.27M |
| 71275 | Computed tomographic angiography, chest, with contrast material | 4,642 | 4,023 | $1.15M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 57,012 | 44,905 | $1.01M |
| 96375 | Therapeutic injection; each additional sequential IV push | 46,932 | 34,330 | $912K |
| 96361 | Intravenous infusion, hydration; each additional hour | 42,394 | 31,733 | $911K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1,955 | 1,683 | $883K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 20,597 | 16,561 | $510K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 12,330 | 11,210 | $427K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 27,322 | 18,692 | $412K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 113,528 | 79,467 | $371K |
| 72125 | Computed tomography, cervical spine; without contrast material | 3,443 | 3,047 | $368K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 10,937 | 9,596 | $357K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 21,431 | 18,208 | $353K |
| 80053 | Comprehensive metabolic panel | 64,141 | 50,047 | $312K |
| 70496 | 978 | 864 | $308K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 4,220 | 3,966 | $299K |
| 96376 | 21,044 | 11,933 | $293K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 9,116 | 7,362 | $286K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 4,562 | 3,977 | $281K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5,483 | 4,930 | $275K |
| 71045 | Radiologic examination, chest; single view | 39,085 | 32,818 | $274K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 54,460 | 43,054 | $273K |
| 59025 | Fetal non-stress test | 7,303 | 5,535 | $261K |
| 84484 | 52,844 | 28,827 | $252K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 4,367 | 3,873 | $233K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,838 | 1,551 | $231K |
| 70498 | 858 | 775 | $231K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,270 | 1,089 | $230K |
| 76801 | 3,677 | 3,009 | $217K | |
| 36415 | Collection of venous blood by venipuncture | 126,303 | 82,051 | $198K |
| 74174 | 385 | 344 | $193K | |
| 72131 | 1,522 | 1,354 | $192K | |
| 84702 | 29,806 | 25,142 | $192K | |
| 0450 | Emergency room services | 4,237 | 3,715 | $189K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 4,456 | 1,629 | $187K |
| 71046 | Radiologic examination, chest; 2 views | 13,982 | 12,276 | $184K |
| 76830 | Ultrasound, transvaginal | 2,516 | 2,205 | $181K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 981 | 847 | $168K |
| 80048 | Basic metabolic panel (calcium, ionized) | 45,026 | 34,873 | $162K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1,945 | 1,676 | $159K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 4,360 | 2,755 | $150K |
| 93971 | 3,054 | 2,666 | $145K | |
| 70486 | 1,038 | 968 | $134K | |
| 93970 | 1,726 | 1,493 | $132K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3,627 | 2,908 | $128K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1,418 | 1,289 | $124K |
| 83880 | 10,151 | 8,469 | $122K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 6,628 | 5,863 | $121K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2,024 | 1,670 | $118K |
| 83690 | 32,090 | 26,229 | $101K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 31,070 | 20,856 | $88K |
| 90715 | 2,247 | 2,052 | $82K | |
| 83605 | 17,840 | 13,211 | $78K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 7,354 | 6,222 | $74K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3,151 | 2,926 | $72K |
| J2785 | Injection, regadenoson, 0.1 mg | 769 | 708 | $71K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2,115 | 1,761 | $70K |
| 81001 | 46,108 | 38,781 | $67K | |
| 95819 | 339 | 290 | $65K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 17,875 | 15,300 | $64K |
| 87040 | 12,961 | 6,988 | $63K | |
| 73564 | 2,825 | 2,552 | $60K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 931 | 799 | $59K |
| 10060 | 855 | 773 | $59K | |
| 97163 | 1,963 | 1,612 | $54K | |
| 73630 | 3,287 | 2,987 | $54K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,992 | 1,574 | $52K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4,561 | 4,326 | $52K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4,991 | 2,275 | $50K |
| 83735 | 20,433 | 13,312 | $48K | |
| 73610 | 2,607 | 2,377 | $48K | |
| 85730 | 22,075 | 17,557 | $47K | |
| 73130 | 2,534 | 2,326 | $46K | |
| 85379 | 9,771 | 8,627 | $45K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 655 | 598 | $44K |
| 81025 | 16,763 | 14,394 | $44K | |
| 70491 | 269 | 238 | $43K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,420 | 2,004 | $42K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,423 | 2,006 | $41K |
| 97167 | 1,565 | 1,312 | $40K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 763 | 729 | $39K |
| 73110 | 1,806 | 1,640 | $39K | |
| 85610 | 27,148 | 21,097 | $37K | |
| 97162 | 1,274 | 1,019 | $37K | |
| 93017 | 1,929 | 1,662 | $34K | |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 585 | 478 | $34K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 12,012 | 8,848 | $34K |
| 73030 | 2,208 | 1,960 | $32K | |
| 12001 | 906 | 831 | $32K | |
| 80061 | Lipid panel | 5,920 | 4,877 | $28K |
| 97116 | 2,949 | 1,972 | $27K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 3,844 | 2,098 | $27K |
| 97535 | Self-care/home management training, each 15 minutes | 2,699 | 1,838 | $26K |
| 72100 | 1,667 | 1,459 | $26K | |
| 84443 | Thyroid stimulating hormone (TSH) | 4,296 | 3,611 | $26K |
| 87186 | 6,836 | 4,946 | $26K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2,244 | 2,036 | $26K |
| 76819 | Fetal biophysical profile; without non-stress testing | 531 | 476 | $25K |
| 80069 | 8,682 | 4,697 | $24K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,480 | 1,287 | $23K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 3,371 | 2,524 | $22K |
| 87641 | 4,143 | 3,303 | $22K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 154 | 131 | $22K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 17,030 | 14,205 | $21K |
| 41899 | Unlisted procedure, dentoalveolar structures | 22 | 21 | $20K |
| J3370 | Injection, vancomycin hcl, 500 mg | 2,592 | 1,498 | $20K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 42,628 | 31,679 | $20K |
| 93880 | 265 | 217 | $19K | |
| 74022 | 862 | 721 | $19K | |
| 76775 | 877 | 758 | $19K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 12,936 | 11,638 | $19K |
| 82962 | 18,963 | 7,415 | $19K | |
| 74018 | 1,528 | 1,347 | $19K | |
| 96367 | 1,186 | 953 | $19K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 8,123 | 5,203 | $19K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 67 | 64 | $18K |
| 29125 | 674 | 607 | $18K | |
| 80076 | 5,239 | 4,352 | $18K | |
| 58661 | 20 | 15 | $18K | |
| 12011 | 400 | 377 | $17K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 16,110 | 13,619 | $17K |
| 83036 | Hemoglobin; glycosylated (A1C) | 5,264 | 4,387 | $17K |
| 97166 | 555 | 454 | $16K | |
| 73080 | 869 | 806 | $16K | |
| J1644 | Injection, heparin sodium, per 1000 units | 10,550 | 4,915 | $15K |
| 82550 | 5,846 | 4,755 | $15K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 2,949 | 2,052 | $15K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 257 | 185 | $14K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 137 | 132 | $13K |
| 81003 | 13,637 | 11,538 | $13K | |
| 85027 | 6,081 | 3,890 | $12K | |
| 73502 | 760 | 656 | $12K | |
| 71101 | 572 | 523 | $12K | |
| 84145 | 1,209 | 962 | $11K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 299 | 280 | $11K |
| 87077 | 2,448 | 1,949 | $11K | |
| 76870 | 380 | 324 | $10K | |
| 73590 | 793 | 718 | $10K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 484 | 389 | $9K |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,592 | 1,285 | $9K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 330 | 288 | $9K |
| 84439 | 2,566 | 2,145 | $9K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2,437 | 2,248 | $9K |
| 86900 | 8,048 | 6,834 | $8K | |
| 86901 | 8,041 | 6,835 | $8K | |
| 82803 | 1,419 | 1,066 | $8K | |
| 73090 | 484 | 437 | $7K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 8,330 | 6,603 | $7K |
| 82140 | 1,420 | 1,055 | $7K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,612 | 933 | $7K |
| J1790 | Injection, droperidol, up to 5 mg | 681 | 608 | $7K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 36 | 26 | $7K |
| J2704 | Injection, propofol, 10 mg | 8,882 | 7,301 | $7K |
| 71250 | 49 | 47 | $7K | |
| 86140 | 3,143 | 2,655 | $7K | |
| 86850 | 5,462 | 4,597 | $6K | |
| 72128 | 68 | 64 | $6K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 2,843 | 2,282 | $6K |
| J2060 | Injection, lorazepam, 2 mg | 8,375 | 6,186 | $6K |
| 97165 | 213 | 156 | $6K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 8,335 | 6,402 | $6K |
| Z7502 | 161 | 145 | $6K | |
| 12002 | 129 | 121 | $6K | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 192 | 168 | $6K |
| 82805 | 456 | 388 | $5K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 256 | 245 | $5K |
| J2791 | Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu | 118 | 102 | $5K |
| 36430 | 344 | 227 | $5K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 8,957 | 7,213 | $5K |
| 72040 | 305 | 266 | $5K | |
| 97161 | 163 | 124 | $5K | |
| J3490 | Unclassified drugs | 403 | 315 | $5K |
| 87210 | 2,172 | 1,853 | $5K | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 846 | 455 | $4K |
| 73140 | 260 | 232 | $4K | |
| 80074 | 315 | 246 | $4K | |
| C9113 | Injection, pantoprazole sodium, per vial | 2,746 | 1,798 | $4K |
| 84112 | 430 | 390 | $4K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 34 | 28 | $4K |
| 82607 | 742 | 563 | $4K | |
| 0250 | 430 | 196 | $4K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 31 | 25 | $4K |
| 84132 | 2,748 | 2,132 | $4K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 14 | 14 | $3K |
| 29515 | 92 | 83 | $3K | |
| 82746 | 574 | 414 | $3K | |
| 87070 | 1,230 | 1,012 | $3K | |
| 87205 | 2,198 | 1,625 | $3K | |
| A9585 | Injection, gadobutrol, 0.1 ml | 180 | 157 | $3K |
| 87631 | 1,724 | 1,405 | $3K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 875 | 595 | $3K |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,004 | 811 | $3K |
| 86923 | 406 | 282 | $3K | |
| 84100 | 1,795 | 1,399 | $3K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 354 | 272 | $3K |
| J1953 | Injection, levetiracetam, 10 mg | 457 | 339 | $3K |
| 11045 | 169 | 65 | $3K | |
| 72193 | 12 | 12 | $3K | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 25 | 13 | $2K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 268 | 179 | $2K |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 611 | 503 | $2K |
| J3480 | Injection, potassium chloride, per 2 meq | 1,690 | 1,162 | $2K |
| J0456 | Injection, azithromycin, 500 mg | 998 | 675 | $2K |
| J1630 | Injection, haloperidol, up to 5 mg | 1,557 | 1,118 | $2K |
| 82010 | 619 | 528 | $2K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 3,556 | 2,710 | $2K |
| 58571 | 18 | 12 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 391 | 354 | $2K |
| 72072 | 99 | 87 | $2K | |
| 99201 | 104 | 95 | $2K | |
| 99070 | 264 | 124 | $2K | |
| G0008 | Administration of influenza virus vaccine | 216 | 185 | $2K |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 1,269 | 1,086 | $2K |
| 87276 | 642 | 596 | $2K | |
| 87275 | 642 | 596 | $2K | |
| J1940 | Injection, furosemide, up to 20 mg | 1,926 | 1,073 | $2K |
| 85652 | 1,544 | 1,312 | $2K | |
| J8540 | Dexamethasone, oral, 0.25 mg | 669 | 613 | $2K |
| 76377 | 44 | 43 | $1K | |
| 49083 | 27 | 12 | $1K | |
| 86780 | 192 | 171 | $1K | |
| 72170 | 140 | 118 | $1K | |
| 82570 | 527 | 452 | $1K | |
| 90686 | 216 | 186 | $1K | |
| 0270 | 156 | 81 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 3,611 | 2,950 | $1K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 17 | 15 | $1K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 88 | 36 | $995.74 |
| 87081 | 594 | 495 | $991.91 | |
| J2358 | Injection, olanzapine, long-acting, 1 mg | 56 | 39 | $990.58 |
| 85018 | 1,187 | 783 | $900.84 | |
| 84550 | 383 | 348 | $877.64 | |
| 85014 | 1,160 | 767 | $875.09 | |
| 87430 | 269 | 251 | $836.55 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 517 | 477 | $830.57 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 879 | 588 | $830.39 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 248 | 210 | $773.61 |
| C1729 | Catheter, drainage | 607 | 384 | $772.06 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 4,225 | 3,513 | $647.98 |
| 87486 | 49 | 37 | $594.35 | |
| 82728 | 179 | 145 | $585.97 | |
| 83550 | 294 | 246 | $580.82 | |
| 87581 | 48 | 36 | $569.69 | |
| 87563 | 34 | 34 | $565.31 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 214 | 148 | $528.10 |
| 83540 | 290 | 249 | $500.49 | |
| J2800 | Injection, methocarbamol, up to 10 ml | 277 | 236 | $478.73 |
| 36600 | 106 | 88 | $440.20 | |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 94 | 43 | $439.37 |
| J7510 | Prednisolone oral, per 5 mg | 76 | 67 | $372.93 |
| J1171 | Injection, hydromorphone, 0.1 mg | 245 | 176 | $336.25 |
| 82248 | 146 | 135 | $330.10 | |
| 84156 | 212 | 181 | $329.06 | |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | 107 | 94 | $307.28 |
| 87420 | 76 | 74 | $279.17 | |
| J3411 | Injection, thiamine hcl, 100 mg | 62 | 50 | $275.35 |
| 83615 | 102 | 84 | $274.33 | |
| 70360 | 13 | 13 | $270.98 | |
| 84300 | 99 | 94 | $211.25 | |
| 97597 | 43 | 24 | $193.55 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 45 | 38 | $149.35 |
| J1836 | Injection, metronidazole, 10 mg | 205 | 139 | $134.50 |
| 73552 | 15 | 15 | $121.07 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 14 | 13 | $82.15 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 869 | 715 | $74.86 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 197 | 126 | $68.21 |
| 84295 | 41 | 37 | $65.87 | |
| J0736 | Injection, clindamycin phosphate, 300 mg | 63 | 56 | $65.12 |
| 85046 | 34 | 24 | $49.72 | |
| A9270 | Non-covered item or service | 24,050 | 3,770 | $18.35 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 27 | 24 | $12.78 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 254 | 237 | $9.90 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 187 | 162 | $1.03 |
| Q0247 | Injection, sotrovimab, 500 mg | 25 | 13 | $0.06 |
| C1769 | Guide wire | 79 | 55 | $0.00 |
| C1781 | Mesh (implantable) | 29 | 25 | $0.00 |
| 0353U | 630 | 584 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 31 | 25 | $0.00 |
| 88312 | 75 | 52 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 31 | 25 | $0.00 |
| 87075 | 22 | 18 | $0.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 48 | 36 | $0.00 |